Syncona
Syncona is a FTSE250 company focused on founding, building, and funding healthcare companies. They aim to deliver transformational treatments for patients in areas of high unmet need, building a diversified portfolio of 20-25 globally leading life science businesses.
Founded 2012 · venture_capital
London (
United Kingdom), St. Peter Port ([object Object])
United Kingdom), St. Peter Port ([object Object])Investment Stages
series-a
series-b
series-c
Portfolio Companies
Autolus Therapeutics, Beacon Therapeutics, iOnctura, Spur Therapeutics, Quell Therapeutics, Anaveon, Resolution Therapeutics, Purespring Therapeutics, Forcefield Therapeutics, OMass Therapeutics, Mosaic Therapeutics, Kesmalea Therapeutics, Yellowstone Biosciences, Slingshot Therapeutics, Gyroscope Therapeutics, Blue Earth, Nightstar, Neogene Therapeutics, 14MG, Azeria Therapeutics, Clade Therapeutics
Related VC firms in United Kingdom